Clinical Study of Utidelone Injection in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）

NCT03693547 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Non-small Cell Lung Cancer

Interventions

DRUG: utidelone injection

Sponsor

Beijing Biostar Pharmaceuticals Co., Ltd.

Collaborators

[object Object]